Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for COPAXONE
- A Window of Opportunity Trial of Intratumoral Injection of Copaxone® in Patients With Percutaneously Accessible Tumors
- A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT
- Efficacy and Safety of BCD-063 and Copaxone-Teva in Patients With Relapsing-Remitting Multiple Sclerosis
- Study to Assess Medication Satisfaction in Patients With Relapsing Remitting Multiple Sclerosis Treated With Copaxone®
- Natalizumab as an Efficacy Switch in Participants With Relapsing Multiple Sclerosis After Failure on Other Therapies
- Safety, Tolerability and Efficacy of Monthly Long-acting IM Injection of 80 or 40 mg GA Depot in Subjects With RRMS
- Pharmacological Treatment of Rett Syndrome With Glatiramer Acetate (Copaxone)
- An Open Label, Exploratory Study to Investigate the Treatment Effect of Glatiramer Acetate on Girls Woth Rett Syndrome
- Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
- Investigating the Neuroprotective Effect of Cop-1 (Copaxone) in Acute Primary Angle Closure
- Study to Assess Whether GSK239512 Can Remyelinate Lesions in Subjects With Relapsing Remitting Multiple Sclerosis
- MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone
- Comparison of Rituximab Induction Therapy Followed by Glatiramer Acetate
- Evaluation of Patient Reported Outcomes in RRMS Patients Candidates for MS Therapy Change and Transitioned to Fingolimod 0.5 mg (EPOC)
- Efficacy and Safety of GTR in Comparison to Copaxone®
- Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition
- Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients
- A Cooperative Clinical Study of Abatacept in Multiple Sclerosis
- A Study in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) Injection 40 mg Administered Three Times a Week Compared to Placebo
- Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis
- The Effects of Ethyl-Alpha-Guanido-Methyl Ethanoate on Skin Reactions From Glatiramer Acetate Injections
- Comparison of 1.5T vs. 3T Protocols After Treatment With Glatiramer Acetate (GA)
- Optical Coherence Tomography: Glatiramer in Clinically Isolated Syndrome or Early Relapsing Remitting Multiple Sclerosis (MS)
- A Randomized, Double-blind, Placebo-controlled, Multicenter Study of the Effects of Glatiramer Acetate (GA) on the Retinal Nerve Fiber Layer (RNFL) and Visual Function in Patients With a First Episode of Acute Optic Neuritis (AON). (Octagon)
- Anti-Inflammatory Type II Monocyte Induction by Glatiramer Acetate (Copaxone) Treatment of Multiple Sclerosis
- A Double Blind Placebo Control Study to Assess the Safety,Tolerability and Efficacy of Copaxone in Crohn's Disease
- Effects of Copaxone in the Retinal Function in Diabetic Patients After Panphotocoagulation
- Weekly Vaccination With Copaxone as a Potential Therapy for Dry Age-related Macular Degeneration
- Comparison of Bone Effects With Copaxone and Interferon in Multiple Sclerosis
- Copaxone in Age Related Macular Degeneration
- BEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New Dose
- A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS)
- Simvastatin as an add-on Treatment to Copaxone for the Treatment of Relapsing Multiple Sclerosis
- An fMRI Study of Treatment Optimization Comparing Two Disease Modifying Therapies Used to Treat Relapsing Remitting Multiple Sclerosis
- fMRI Study of Treatment Recommendations Comparing Recently Diagnosed Multiple Sclerosis (MS) Patients to Controls
- Clinical Trial Comparing Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) With Two Doses of Glatiramer Acetate (GA).
- Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS)
- FOCUS Fatigue Outcome in Copaxone USers
- A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.
- A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone®
- Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline
- Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine
- A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis.
- Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate
- Glatiramer Acetate (Copaxone®) Study to Follow Participants From the First Original Study for Safety and Effectiveness
- Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatment of RRMS
- A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose
- Phase IV Study, Betaseron Versus Copaxone for Relapsing Remitting or CIS Forms of MS Using Triple Dose Gad 3 T MRI
- Implementation Study of Treatment Optimization Recommendations on Relapsing-Remitting Multiple Sclerosis (RR MS) Subjects
- BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
- Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis
- Treatment of Multiple Sclerosis With Copaxone and Albuterol
Clinical trials list
click for details